This grant from the National Institute on Drug Abuse (NIDA) aims to foster the creation of innovative, cost-effective technologies designed to significantly reduce or eliminate disparities in Substance Use Disorder (SUD) treatment. The initiative specifically targets barriers related to geographical access, including rural-urban divides, high treatment costs, and the pervasive issue of stigma. The core objective is to shift the paradigm by bringing necessary SUD treatment directly to the patient, rather than requiring patients to travel for care. By supporting the development of field-deployable, point-of-need solutions, this funding seeks to enhance accessibility and improve outcomes for individuals affected by SUD across diverse populations.
Opportunity ID: 348338
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-24-017 |
Funding Opportunity Title: | Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 23, 2023 |
Last Updated Date: | May 23, 2023 |
Original Closing Date for Applications: | Nov 09, 2023 |
Current Closing Date for Applications: | Nov 09, 2023 |
Archive Date: | Dec 15, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | $295,924 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See full Notice of Funding Opportunity for additional details on eligibility. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The FOA intends to spur the development of cost-effective technologies that may reduce or even eliminate disparities in SUD treatment. Disparities due to geographical access or rural/urban divide, due to treatment cost, or due to stigma will be specifically targeted. The intention is to bring to the treatment to the patient, not the patient to the treatment. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-017.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 348338 Full Announcement-RFA-DA-24-017 -> RFA-DA-24-017-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00281854 | Oct 09, 2023 | Nov 09, 2023 | View |
Package 1
Mandatory forms
348338 RR_SF424_5_0-5.0.pdf
348338 PHS398_CoverPageSupplement_5_0-5.0.pdf
348338 RR_OtherProjectInfo_1_4-1.4.pdf
348338 PerformanceSite_4_0-4.0.pdf
348338 RR_KeyPersonExpanded_4_0-4.0.pdf
348338 RR_Budget_3_0-3.0.pdf
348338 RR_SubawardBudget30_3_0-3.0.pdf
348338 PHS398_ResearchPlan_5_0-5.0.pdf
348338 SBIR_STTR_Information_3_0-3.0.pdf
348338 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
348338 PHS_AssignmentRequestForm_3_0-3.0.pdf